Endocrine Treatment in Breast Cancer

Endocrine therapy benefits for stage 1 breast cancerПодробнее

Health and Wellness Thursdays: Endocrine Therapy and Hormone Use After Breast CancerПодробнее

Can vaginal estrogen be an issue with endocrine therapy?Подробнее

02_03 Adjuvant endocrine therapy for early breast cancerПодробнее

Partnering to Provide Personalized Care: Patient Selection for Extended Endocrine TherapyПодробнее

Palbociclib, pembrolizumab, and endocrine therapy in HR+/HER2- breast cancerПодробнее

What I Tell My Patients: Hormonal Therapy for Hormone Receptor-Positive Breast CancerПодробнее

Endocrine Therapy for DCIS | 2024 Ductal Carcinoma In Situ Patient ForumПодробнее

Defining Endocrine therapy for Early Breast cancer patientsПодробнее

RSClin N+ in planning treatment for lymph node-positive breast cancerПодробнее

Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?Подробнее

RxPONDER: chemotherapy and endocrine therapy in HR+/HER2- breast cancerПодробнее

Addressing the Challenge of Endocrine-Resistant Breast CancerПодробнее

Role of endocrine therapy in early-stage HR-positive breast cancerПодробнее

PATRICIA: Phase II study of palbociclib, trastuzumab, and endocrine therapy in HER2+ advanced BCПодробнее

Updated safety findings of PF-07220060 and endocrine therapy in HR+/HER2- breast cancerПодробнее

Latest Advances in Systemic Treatment for Breast Cancer: Evidence and ImplicationsПодробнее

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2...Подробнее

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast CancerПодробнее

ASCO 2024 Palbociclib, Pembrolizumab & Endocrine Therapy: Outcomes & Gut Microbiome in HR+/HER2- MBCПодробнее